Cargando…
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A.
Antibody targeted therapy of cancer results in anti-antibody production which prevents repeated treatment. Cyclosporin A (CsA) has been used to suppress this response in patients treated with a radiolabelled antibody to carcinoembryonic antigen (CEA). Patients with CEA producing tumours received a m...
Autores principales: | Ledermann, J. A., Begent, R. H., Bagshawe, K. D., Riggs, S. J., Searle, F., Glaser, M. G., Green, A. J., Dale, R. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246821/ https://www.ncbi.nlm.nih.gov/pubmed/3265333 |
Ejemplares similares
-
Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits.
por: Ledermann, J. A., et al.
Publicado: (1988) -
Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.
por: Begent, R. H., et al.
Publicado: (1989) -
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.
por: Philip, P. A., et al.
Publicado: (1991) -
The clinical value of imaging with antibody to human chorionic gonadotrophin in the detection of residual choriocarcinoma.
por: Begent, R. H., et al.
Publicado: (1987) -
Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.
por: Pedley, R. B., et al.
Publicado: (1990)